Jose Inzunza

Dr. Jose Inzunza


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2010 in Nature Biotechnology
Verified
Journal Article
Closed access
SRSergey A. Rodin
Sergey A. Rodin
ADAnna Domogatskaya
Anna Domogatskaya
SSSusanne Ström
Susanne Ström
EHEmil M Hansson
Emil M Hansson
KCKenneth R Chien
Kenneth R Chien
KTKarl Tryggvason
Karl Tryggvason

1 July 2003 in Human Reproduction
Verified
Journal Article
Closed access
PDF file
OHOuti Hovatta
Outi Hovatta
MMMilla Mikkola
Milla Mikkola
KGKarin Gertow
Karin Gertow
ASAnne‐Marie Strömberg
Anne‐Marie Strömberg
Jose InzunzaJose Inzunza
Jose Inzunza
LÄLars Ährlund‐Richter
Lars Ährlund‐Richter
BACKGROUND: Human embryonic stem (hES) cell lines were first cultured using fetal mouse fibroblasts as feeder cells. To avoid feeders and to reduce the amount of xeno‐components, Matrigel‐ and laminin‐coated dishes, and conditioned mouse feeder cell medium have been used, and hES cells have also been cultured on human fetal muscle and skin, and adult Fallopian tube epithelial cells. METHODS: We used post‐natal, commercially available human foreskin fibroblasts as feeder cells. Inner cell masses (ICM) were isolated from five supernumerary blastocysts, obtained as donations from couples undergoing IVF treatment. RESULTS: Two ICM showed continuous growth. One line, HS181, has been in culture for 41 weeks with a doubling time of 24–36 h. It continues to express stem cell markers alkaline phosphatase, Oct‐4, stage‐specific embryonic antigen (SSEA)‐4 and tumour‐related antigen (TRA)‐1‐60. The karyotype is 46,XX. Pluripotency was demonstrated by teratoma formation in immunodeficient mice. In high‐density cultures, spontaneous differentiation to beating cells and neuron‐like cells was seen. The second line, HS207, was cultured for 9 weeks and cryopreserved, as were samples of line HS181. Both lines began to grow after thawing. CONCLUSIONS: We used successfully human foreskin fibroblasts as feeder cells for derivation and continued undifferentiated growth of hES cells. These feeder cells are convenient for IVF units, because no fetal human tissues or tissue from operations are needed.

27 January 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
SRSergey A. Rodin
Sergey A. Rodin
LALiselotte Antonsson
Liselotte Antonsson
CNColin Niaudet
Colin Niaudet
OSOscar E. Simonson
Oscar E. Simonson
ESElina Salmela
Elina Salmela
KTKarl Tryggvason
Karl Tryggvason
Lack of robust methods for establishment and expansion of pluripotent human embryonic stem (hES) cells still hampers development of cell therapy. Laminins (LN) are a family of highly cell-type specific basement membrane proteins important for cell adhesion, differentiation, migration and phenotype stability. Here we produce and isolate a human recombinant LN-521 isoform and develop a cell culture matrix containing LN-521 and E-cadherin, which both localize to stem cell niches in vivo. This matrix allows clonal derivation, clonal survival and long-term self-renewal of hES cells under completely chemically defined and xeno-free conditions without ROCK inhibitors. Neither LN-521 nor E-cadherin alone enable clonal survival of hES cells. The LN-521/E-cadherin matrix allows hES cell line derivation from blastocyst inner cell mass and single blastomere cells without a need to destroy the embryo. This method can facilitate the generation of hES cell lines for development of different cell types for regenerative medicine purposes.

1 April 2005 in Stem Cells
Verified
Journal Article
Closed access
PDF file
Jose InzunzaJose Inzunza
Jose Inzunza
KGKarin Gertow
Karin Gertow
MSMarie A. Strömberg
Marie A. Strömberg
EMEija Matilainen
Eija Matilainen
EBElisabeth Blennow
Elisabeth Blennow
OHOuti Hovatta
Outi Hovatta
Derivation and culture of human embryonic stem cells (hESCs) without animal-derived material would be optimal for cell transplantation. We derived two new hES (HS293 and HS306) and 10 early cell lines using serum replacement (SR) medium instead of conventional fetal calf serum and human foreskin fibroblasts as feeder cells. Line HS293 has been in continuous culture, with a passage time of 5-8 days, since October 2003 and is at passage level 56. Line HS306 has been cultured since February 2004, now at passage 41. The lines express markers of pluripotent hESCs (Oct-4, SSEA-4, TRA-1-60, TRA-1-81, GCTM-2, and alkaline phosphatase). The pluripotency has been shown in embryoid bodies in vitro, and the pluripotency of line 293 has also been shown in vivo by teratoma formation in severe combined immunodeficiency/beige mice. The karyotype of HS293 is 46,XY, and that of HS306 is 46,XX. Ten more early lines have been derived under similar conditions since September 2004. We conclude that hESC lines can be successfully derived using SR medium and postnatal human fibroblasts as feeder cells. This is a step toward xeno-free conditions and facilitates the use of these cells in transplantation.

28 July 2006 in Endocrine Reviews
Verified
Journal Article
Open access
PDF file
UOUlrich Ohnemus
Ulrich Ohnemus
MUMurat Uenalan
Murat Uenalan
Jose InzunzaJose Inzunza
Jose Inzunza
JGJan-ÅkE Gustafsson
Jan-ÅkE Gustafsson
RPRalf Paus
Ralf Paus
For many decades, androgens have dominated endocrine research in hair growth control. Androgen metabolism and the androgen receptor currently are the key targets for systemic, pharmacological hair growth control in clinical medicine. However, it has long been known that estrogens also profoundly alter hair follicle growth and cycling by binding to locally expressed high-affinity estrogen receptors (ERs). Besides altering the transcription of genes with estrogen-responsive elements, 17β-estradiol (E2) also modifies androgen metabolism within distinct subunits of the pilosebaceous unit (i.e., hair follicle and sebaceous gland). The latter displays prominent aromatase activity, the key enzyme for androgen conversion to E2, and is both an estrogen source and target. Here, we chart the recent renaissance of estrogen research in hair research; explain why the hair follicle offers an ideal, clinically relevant test system for studying the role of sex steroids, their receptors, and interactions in neuroectodermal-mesodermal interaction systems in general; and illustrate how it can be exploited to identify novel functions and signaling cross talks of ER-mediated signaling. Emphasizing the long-underestimated complexity and species-, gender-, and site-dependence of E2-induced biological effects on the hair follicle, we explore targets for pharmacological intervention in clinically relevant hair cycle manipulation, ranging from androgenetic alopecia and hirsutism via telogen effluvium to chemotherapy-induced alopecia. While defining major open questions, unsolved clinical challenges, and particularly promising research avenues in this area, we argue that the time has come to pay estrogen-mediated signaling the full attention it deserves in future endocrinological therapy of common hair growth disorders.

1 December 2006 in Cancer Research
Verified
Journal Article
Open access
PDF file
JHJohan Hartman
Johan Hartman
KLKarolina Lindberg
Karolina Lindberg
AMAndrea Morani
Andrea Morani
Jose InzunzaJose Inzunza
Jose Inzunza
ASAnders Ström
Anders Ström
JGJan-Åke Gustafsson
Jan-Åke Gustafsson
Estrogens, which are stimulators of growth of both the normal breast and malignant breast, mediate their effects through two estrogen receptors (ER), namely ERα and ERβ. ERα mediates the proliferative effect of estrogen in breast cancer cells, whereas ERβ seems to be antiproliferative. We engineered ERα-positive T47D breast cancer cells to express ERβ in a Tet-Off–regulated manner. These cells were then injected orthotopically into severe combined immunodeficient mice, and the growth of the resulting tumors was compared with tumors resulting from injecting the parental T47D cells that do not express ERβ. The presence of ERβ resulted in a reduction in tumor growth. Comparison of the ERβ-expressing and non-ERβ–expressing tumors revealed that the expression of ERβ caused a reduction in the number of intratumoral blood vessels and a decrease in expression of the proangiogenic factors vascular endothelial growth factor (VEGF) and platelet-derived growth factor β (PDGFβ). In cell culture, with the Tet-Off–regulated ERβ-expressing cells, expression of ERβ decreased expression of VEGF and PDGFβ mRNA under normoxic as well as hypoxic conditions and reduced secreted VEGF and PDGFβ proteins in cell culture medium. Transient transfection assays with 1,026 bp VEGF and 1,006 bp PDGFβ promoter constructs revealed a repressive effect of ERβ at the promoter level of these genes. Taken together, these data show that introduction of ERβ into malignant cells inhibits their growth and prevents tumor expansion by inhibiting angiogenesis. (Cancer Res 2006; 66(23): 11207-13)